Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Akhurst

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Excess Muscle FDG Uptake in an Euglycaemic Patient That Is Corrected by FastingTimothy Akhurst, Patrick Boland, Homer Macapinlac, et al.
EJNMMI Research|February 10, 2019
Personalised insulin calculator enables safe and effective correction of hyperglycaemia prior to FDG PET/CTDavid A Pattison, Lisa L MacFarlane, Jason Callahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resectionRobert J Downey, Timothy Akhurst, Mithat Gonen, et al.
The Annals of Thoracic Surgery|February 21, 2006
Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resectionNabil Rizk, Robert J Downey, Timothy Akhurst, et al.
Nature Biotechnology|May 11, 2004
Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitorsPeter M Smith-Jones, David B Solit, Timothy Akhurst, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 27, 2006
Positron emission tomography predicts survival in malignant pleural mesotheliomaRaja M Flores, Timothy Akhurst, Mithat Gonen, et al.
Internal Medicine Journal|December 14, 2020
Utility of <sup>68</sup> Ga-DOTA-Exendin-4 positron emission tomography-computed tomography imaging in distinguishing between insulinoma and nesidioblastosis in patients with confirmed endogenous hyperinsulinaemic hypoglycaemiaVictor Kalff, Amir Iravani, Timothy Akhurst, et al.
Annals of Surgical Oncology|May 8, 2014
Systematic review of FDG-PET prediction of complete pathological response and survival in rectal cancerSameer Memon, A Craig Lynch, Timothy Akhurst, et al.
Journal of the American College of Surgeons|December 25, 2007
18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancerCarlos U Corvera, Leslie H Blumgart, Timothy Akhurst, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 12, 2014
Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumoursRaghava Kashyap, Michael S Hofman, Michael Michael, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Excess Muscle FDG Uptake in an Euglycaemic Patient That Is Corrected by FastingTimothy Akhurst, Patrick Boland, Homer Macapinlac, et al.
EJNMMI Research|February 10, 2019
Personalised insulin calculator enables safe and effective correction of hyperglycaemia prior to FDG PET/CTDavid A Pattison, Lisa L MacFarlane, Jason Callahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resectionRobert J Downey, Timothy Akhurst, Mithat Gonen, et al.
The Annals of Thoracic Surgery|February 21, 2006
Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resectionNabil Rizk, Robert J Downey, Timothy Akhurst, et al.
Nature Biotechnology|May 11, 2004
Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitorsPeter M Smith-Jones, David B Solit, Timothy Akhurst, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 27, 2006
Positron emission tomography predicts survival in malignant pleural mesotheliomaRaja M Flores, Timothy Akhurst, Mithat Gonen, et al.
Internal Medicine Journal|December 14, 2020
Utility of <sup>68</sup> Ga-DOTA-Exendin-4 positron emission tomography-computed tomography imaging in distinguishing between insulinoma and nesidioblastosis in patients with confirmed endogenous hyperinsulinaemic hypoglycaemiaVictor Kalff, Amir Iravani, Timothy Akhurst, et al.
Annals of Surgical Oncology|May 8, 2014
Systematic review of FDG-PET prediction of complete pathological response and survival in rectal cancerSameer Memon, A Craig Lynch, Timothy Akhurst, et al.
Journal of the American College of Surgeons|December 25, 2007
18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancerCarlos U Corvera, Leslie H Blumgart, Timothy Akhurst, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 12, 2014
Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumoursRaghava Kashyap, Michael S Hofman, Michael Michael, et al.
Pageof 4